Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer

Homozygous Deletions and Recurrent Amplifications Implicate New Genes Involved in Prostate Cancer

(2015) Wennuan Liu et al.   NEOPLASIA

Light at Night Activates IGF-1R/PDK1 Signaling and Accelerates Tumor Growth in Human Breast Cancer Xenografts

(2011) J. Wu et al.   CANCER RESEARCH

Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin

(2011) M. D. Mediavilla et al.   CURRENT MEDICINAL CHEMISTRY

Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells

(2011) Sung-Yun Cho et al.   JOURNAL OF PINEAL RESEARCH

Novel targets for prostate cancer chemoprevention

(2010) Fazlul H Sarkar et al.   ENDOCRINE-RELATED CANCER

Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gαs and Gαq proteins

(2010) Stephen Y. W. Shiu et al.   JOURNAL OF PINEAL RESEARCH

Pharmacokinetics of orally administered melatonin in critically ill patients

(2010) Giovanni Mistraletti et al.   JOURNAL OF PINEAL RESEARCH

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

(2010) Howard I Scher et al.   LANCET

Chemoprevention of Prostate Cancer

(2010) Patrick C. Walsh   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Dutasteride on the Risk of Prostate Cancer

(2010) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Steroid Hormone Receptors in Prostate Cancer: A Hard Habit to Break?

(2009) Gerhardt Attard et al.   CANCER CELL

Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven

(2009) G. Attard et al.   CANCER RESEARCH

Global Co‐Distribution of Light at Night (LAN) and Cancers of Prostate, Colon, and Lung in Men

(2009) Itai Kloog et al.   CHRONOBIOLOGY INTERNATIONAL

Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line

(2009) Gemma Marcias et al.   HUMAN MUTATION

Light-Mediated Perturbations of Circadian Timing and Cancer Risk: A Mechanistic Analysis

(2009) Russel J. Reiter et al.   INTEGRATIVE CANCER THERAPIES

Light-at-night, circadian disruption and breast cancer: assessment of existing evidence

(2009) R. G Stevens   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer

(2009) Gerhardt Attard et al.   JOURNAL OF CLINICAL ONCOLOGY

Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer

(2009) Seong Soo Joo et al.   JOURNAL OF PINEAL RESEARCH

Melatonin down-regulates HIF-1α expression through inhibition of protein translation in prostate cancer cells

(2009) Jong-Wook Park et al.   JOURNAL OF PINEAL RESEARCH

Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer

(2009) Brittney Jung-Hynes et al.   JOURNAL OF PINEAL RESEARCH

Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target

(2009) Yu Chen et al.   LANCET ONCOLOGY

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

(2009) C. Tran et al.   SCIENCE

A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression

(2008) Pradip K. Majumder et al.   CANCER CELL

Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy Resistance

(2008) S. M. Dehm et al.   CANCER RESEARCH

Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer

(2008) R. Hu et al.   CANCER RESEARCH

Therapeutic Actions of Melatonin in Cancer: Possible Mechanisms

(2008) Venkataramanujan Srinivasan et al.   INTEGRATIVE CANCER THERAPIES

Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance

(2008) Chun W. Tam et al.   JOURNAL OF PINEAL RESEARCH

Melatonin, sleep disturbance and cancer risk

(2008) David E. Blask   SLEEP MEDICINE REVIEWS